Michael J. Morris, MD

Michael J. Morris, MD

I am a board-certified medical oncologist who specializes in treating men with prostate cancer, particularly those who have metastatic disease (disease that has spread to distant organs) or who are at high risk of developing metastatic disease.

Much of my research bridges the fields of medical oncology and nuclear medicine. I am working with colleagues on Memorial Sloan Kettering’s Nuclear Medicine Service to develop radiopharmaceuticals — liquid drugs that deliver radiation therapy directly to cancer cells or to the areas in the skeleton that harbor prostate cancer cells. I am exploring one class of these drugs, called bone-seeking radiopharmaceuticals, in combination with chemotherapy. I am also exploring a new form of bone-seeking radiopharmaceutical that has fewer side effects in the bone marrow.

Appointments for New Patients
Clinical Expertise

Prostate Cancer; New Investigational Agents

Languages Spoken

MD, Mount Sinai School of Medicine


Columbia-Presbyterian Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications

Medical Oncology

Publications by Michael J. Morris
Visit PubMed for full listing of Michael J. Morris journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.